Role of rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 4, 2012, Pages 1885-1891

  Tafin, Ulrika Furustrand ^a   Corvec, Stéphane ^a,b   Betrisey, Bertrand ^a   Zimmerli, Werner ^c   Trampuz, Andrej ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c Kantonsspital Liestal   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CLINDAMYCIN; DAPTOMYCIN; LEVOFLOXACIN; PENICILLIN G; RIFAMPICIN; VANCOMYCIN;

ACTINOMYCETALES INFECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOFILM; COLONY FORMING UNIT; CONTROLLED STUDY; EXPERIMENTAL GUINEA PIG; FOREIGN BODY REACTION; IN VITRO STUDY; IN VIVO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANKTON; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROSTHESIS INFECTION; TREATMENT DURATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; CALORIMETRY; FOREIGN BODIES; GRAM-POSITIVE BACTERIAL INFECTIONS; GUINEA PIGS; MALE; MICROBIAL SENSITIVITY TESTS; PROPIONIBACTERIUM ACNES; RIFAMPIN;

EID: 84858638953     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05552-11     Document Type: Article

References (45)

1. Baldoni D, Haschke M, Rajacic Z, Zimmerli W, Trampuz A. 2009. Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection. Antimicrob. Agents Chemother. 53:1142-1148.
2. Bayston R, et al. 2007. Biofilm formation by Propionibacterium acnes on biomaterials in vitro and in vivo: impact on diagnosis and treatment. J. Biomed. Mater. Res. A 81:705-709. (Pubitemid 46786902)
3. Bayston R, Nuradeen B, Ashraf W, Freeman BJ. 2007. Antibiotics for the eradication of Propionibacterium acnes biofilms in surgical infection. J. Antimicrob. Chemother. 60:1298-1301. (Pubitemid 350168326)
4. Bemer P, et al. 2008. Significance of Propionibacterium acnes-positive samples in spinal instrumentation. Spine 33:E971-E976.
5. Blaser J, Vergeres P, Widmer AF, Zimmerli W. 1995. In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob. Agents Chemother. 39:1134-1139.
6. Boling EA, Blanchard GC, Russell WJ. 1973. Bacterial identification by microcalorimetry. Nature 241:472-473.
7. Butler-Wu SM, et al. 2011. Optimization of periprosthetic culture for the diagnosis of Propionibacterium acnes prosthetic joint infection. J. Clin. Microbiol. 49:2490-2495.
8. Clauss M, Trampuz A, Borens O, Bohner M, and Illchmann T. 2010. Biofilm formation on bone grafts and bone graft substitutes: comparison of different materials by a standard in vitro test and by microcalorimetry. Acza Biomater. 6:3791-3797.
9. Clinical and Laboratory Standards Institute. 1999. Methods for determining bactericidal activity of antimicrobial agents; approved guideline M26-A. CLSI, Wayne, PA.
10. Conen A, et al. 2008. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period. Clin. Infect. Dis. 47:73-82. (Pubitemid 351920591)
11. Del Pozo JL, et al. 2009. Pilot study of association of bacteria on breast implants with capsular contracture. J. Clin. Microbiol. 47:1333-1337.
12. Furustrand Tafin U, et al. 2011. Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model. Antimicrob. Agents Chemother. 55:4821-4827.
13. Ghosh M, Talwani R, Gilliam BL. 2009. Propionibacterium skull osteomyelitis treated with daptomycin. Clin. Neurol. Neurosurg. 111:610-612.
14. Haidar R, Najjar M, Der BA, Tabbarah Z. 2010. Propionibacterium acnes causing delayed postoperative spine infection: review. Scand. J. Infect. Dis. 42:405-411.
15. Hall GS, et al. 1995. Minimum bactericidal concentrations of Propionibacterium acnes isolates from cases of chronic endophthalmitis. Diagn. Microbiol. Infect. Dis. 21:187-190.
16. Hoeffler U, Ko HL, Pulverer G. 1976. Antimicrobiol. susceptibility of Propinibacterium acnes and related microbial species. Antimicrob. Agents Chemother. 10:387-394.
17. Jakab E, et al. 1996. Severe infections caused by Propionibacterium acnes: an underestimated pathogen in late postoperative infections. Yale J. Biol. Med. 69:477-482. (Pubitemid 126686728)
18. John AK, et al. 2009. Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin. Antimicrob. Agents Chemother. 53:2719-2724.
19. Kowalski TJ, et al. 2007. The management and outcome of spinal implant infections: contemporary retrospective cohort study. Clin. Infect. Dis. 44: 913-920. (Pubitemid 46452054)
20. Levy PY, et al. 2008. Propionibacterium acnes postoperative shoulder arthritis: an emerging clinical entity. Clin. Infect. Dis. 46:1884-1886.
21. Lutz MF, et al. 2005. Arthroplastic and osteosynthetic infections due to Propionibacterium acnes: a retrospective study of 52 cases, 1995-2002. Eur. J. Clin. Microbiol. Infect. Dis. 24:739-744.
22. Mathur T, Bhateja P, Pandya M, Fatma T, Rattan A. 2004. In vitro activity of RBx 7644 (ranbezolid) on biofilm producing bacteria. Int. J. Antimicrob. Agents 24:369-373. (Pubitemid 39369482)
23. Nord CE, Oprica C. 2006. Antibiotic resistance in Propionibacterium acnes. Microbiological and clinical aspects. Anaerobe 12:207-210. (Pubitemid 44666468)
24. Perry AL, Lambert PA. 2006. Propionibacterium acnes. Lett. Appl. Microbiol. 42:185-188.
25. Piper KE, et al. 2009. Microbiologic diagnosis of prosthetic shoulder infection by use of implant sonication. J. Clin. Microbiol. 47:1878-1884.
26. Ramage G, Tunney MM, Patrick S, Gorman SP, Nixon JR. 2003. Formation of Propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials. Biomaterials 24:3221-3227. (Pubitemid 36577671)
27. Rieger UM, Pierer G, Luscher NJ, Trampuz A. 2009. Sonication of removed breast implants for improved detection of subclinical infection. Aesthetic Plast Surg. 33:404-408.
28. Rohacek M, et al. 2010. Bacterial colonization and infection of electrophysiological cardiac devices detected with sonication and swab culture. Circulation 121:1691-1697.
29. Sampedro MF, et al. 2010. A biofilm approach to detect bacteria on removed spinal implants. Spine 35:1218-1224.
30. Soderquist B, Holmberg A, Unemo M. 2010. Propionibacterium acnes as an etiological agent of arthroplastic and osteosynthetic infections - two cases with specific clinical presentation including formation of draining fistulae. Anaerobe 16:304-306.
31. Trampuz A, et al. 2007. Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection. Antimicrob. Agents Chemother. 51:2540-2545. (Pubitemid 47047334)
32. Trampuz A, et al. 2007. Sonication of removed hip and knee prostheses for diagnosis of infection. N. Engl. J. Med. 357:654-663. (Pubitemid 47267235)
33. Trampuz A, Widmer AF. 2006. Infections associated with orthopedic implants. Curr. Opin. Infect. Dis. 19:349-356. (Pubitemid 43982507)
34. Tunney MM, et al. 1999. Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16S rRNA gene. J. Clin. Microbiol. 37:3281-3290. (Pubitemid 29455221)
35. Vergidis P, et al. 2011. Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis. Antimicrob. Agents Chemother. 55:1182-1186.
36. Wadsö I. 2001. Isothermal microcalorimety: current problems and prospects. J. Therm Anal. Calorim. 64:75-84.
37. Webster GF, Leyden JJ, Musson RA, Douglas SD. 1985. Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro. Infect. Immun. 49:116-121. (Pubitemid 15062878)
38. Widmer AF, Frei R, Rajacic Z, Zimmerli W. 1990. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J. Infect. Dis. 162:96-102. (Pubitemid 20223955)
39. Widmer AF, Gaechter A, Ochsner PE, Zimmerli W. 1992. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin. Infect. Dis. 14:1251-1253.
40. Zappe B, Graf S, Ochsner PE, Zimmerli W, Sendi P. 2008. Propionibacterium spp. in prosthetic joint infections: a diagnostic challenge. Arch. Orthop. Trauma Surg. 128:1039-1046.
41. Zeller V, et al. 2007. Propionibacterium acnes: an agent of prosthetic joint infection and colonization. J. Infect. 55:119-124. (Pubitemid 47029748)
42. Zimmerli W, Frei R, Widmer AF, Rajacic Z. 1994. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J. Antimicrob. Chemother. 33:959-967. (Pubitemid 24170895)
43. Zimmerli W, Trampuz A, Ochsner PE. 2004. Prosthetic-joint infections. N. Engl. J. Med. 351:1645-1654.
44. Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE. 1982. Pathogenesis of foreign body infection: description and characteristics of an animal model. J. Infect. Dis. 146:487-497. (Pubitemid 12004448)
45. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. 1998. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 279:1537-1541. (Pubitemid 28233008)